OKYO
Price:
$1.065
Market Cap:
$36.09M
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.[Read more]
Industry
Biotechnology
IPO Date
2022-05-17
Stock Exchange
NASDAQ
Ticker
OKYO
According to OKYO Pharma Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 35.26M. This represents a change of -96.18% compared to the average of 924.00M of the last 4 quarters.
The mean historical Enterprise Value of OKYO Pharma Limited over the last ten years is 1.56B. The current 35.26M Enterprise Value has changed 126.58% with respect to the historical average. Over the past ten years (40 quarters), OKYO's Enterprise Value was at its highest in in the March 2022 quarter at 3.79B. The Enterprise Value was at its lowest in in the March 2014 quarter at -11806956.50.
Average
1.56B
Median
1.38B
Minimum
35.56M
Maximum
3.54B
Discovering the peaks and valleys of OKYO Pharma Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 45.85%
Maximum Annual Enterprise Value = 3.54B
Minimum Annual Increase = -99.00%
Minimum Annual Enterprise Value = 35.56M
Year | Enterprise Value | Change |
---|---|---|
2024 | 42.31M | 18.97% |
2023 | 35.56M | -99.00% |
2022 | 3.54B | 45.85% |
2021 | 2.43B | 12.68% |
2020 | 2.16B | 15.90% |
2019 | 1.86B | 34.17% |
2018 | 1.39B | 0.45% |
2017 | 1.38B | 0.37% |
2016 | 1.37B | 1.17% |
2015 | 1.36B | 26.10% |
The current Enterprise Value of OKYO Pharma Limited (OKYO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.21B
5-year avg
1.64B
10-year avg
1.56B
OKYO Pharma Limited’s Enterprise Value is less than Bionomics Limited (1.26B), less than Candel Therapeutics, Inc. (390.85M), less than Anebulo Pharmaceuticals, Inc. (40.61M), greater than Cingulate Inc. (5.81M), less than Unicycive Therapeutics, Inc. (0), less than Quoin Pharmaceuticals, Ltd. (38.02M), greater than Cardio Diagnostics Holdings, Inc. (-667131.00), less than Virax Biolabs Group Limited (39.58M), greater than PaxMedica, Inc. Common Stock (4.10M), greater than Senti Biosciences, Inc. (371.78K), less than ZIVO Bioscience, Inc. (43.36M), less than Cadrenal Therapeutics, Inc. Common Stock (78.24M), greater than Foghorn Therapeutics Inc. (20.14M), less than Clearmind Medicine Inc. (260.47M), greater than Hillstream BioPharma, Inc. (-79586.00), greater than Coeptis Therapeutics, Inc. (1.48M), greater than Magenta Therapeutics, Inc. (6.48M), greater than null (-114170976.00),
Company | Enterprise Value | Market cap |
---|---|---|
1.26B | $8.81M | |
390.85M | $391.38M | |
40.61M | $42.01M | |
5.81M | $18.66M | |
0 | $69.56M | |
38.02M | $2.45M | |
-667131.00 | $40.84M | |
39.58M | $7.47M | |
4.10M | $696.27K | |
371.78K | $19.13M | |
43.36M | $78.37M | |
78.24M | $24.50M | |
20.14M | $279.08M | |
260.47M | $7.54M | |
-79586.00 | $4.17M | |
1.48M | $5.84M | |
6.48M | $42.44M | |
-114170976.00 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OKYO Pharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OKYO Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is OKYO Pharma Limited's Enterprise Value?
What is the highest Enterprise Value for OKYO Pharma Limited (OKYO)?
What is the 3-year average Enterprise Value for OKYO Pharma Limited (OKYO)?
What is the 5-year average Enterprise Value for OKYO Pharma Limited (OKYO)?
How does the current Enterprise Value for OKYO Pharma Limited (OKYO) compare to its historical average?